Table 1.

Expression of four serum exosome‐derived miRNAs in NSCLC patients and healthy controls in training set (median [interquartile range])

	Training set
miRNA	Controls (n = 74)	NSCLCs (n = 74)	P‐value
hsa‐miR‐9‐3p	1.050 (0.6256–1.552)	3.541(1.860–6.057)	<0.0001
hsa‐miR‐205‐5p	0.9346 (0.6232–1.561)	2.219 (1.331–4.714)	<0.0001
hsa‐miR‐210‐5p	1.083 (0.6880–1.559)	2.333(1.467–3.574)	<0.0001
hsa‐miR‐1269a	1.149 (0.7067–1.675)	2.585 (1.708–4.233)	<0.0001